Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer.

Autor: Ci, Xinpei1 (AUTHOR), Chen, Sujun1,2 (AUTHOR), Zhu, Rui1 (AUTHOR), Zarif, Mojgan1 (AUTHOR), Jain, Rahi1 (AUTHOR), Guo, Wangyuan1 (AUTHOR), Ramotar, Matthew1 (AUTHOR), Gong, Linsey1,3 (AUTHOR), Xu, Wenjie4 (AUTHOR), Singh, Olivia1 (AUTHOR), Mansouri, Sheila1 (AUTHOR), Zadeh, Gelareh1,5 (AUTHOR), Wei, Gong-Hong4 (AUTHOR), Xu, Wei1 (AUTHOR), Bristow, Robert6,7 (AUTHOR), Berlin, Alejandro1 (AUTHOR) alejandro.berlin@rmp.uhn.ca, Koritzinsky, Marianne1,3,8,9 (AUTHOR) marianne.koritzinsky@uhnresearch.ca, van der Kwast, Theodorus1,10 (AUTHOR) theodorus.vanderkwast@uhn.ca, He, Housheng Hansen1,3 (AUTHOR) hansenhe@uhnresearch.ca
Zdroj: BMC Cancer. 6/18/2024, Vol. 24 Issue 1, p1-12. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje